# Ureter mixed neuroendocrine-non-neuroendocrine neoplasm: a case report and literature review

**Authors:** Bing Zhou, Xing Gan, Xiaohua Li, Lizi Peng, Hua Hao

PMC · DOI: 10.3389/fonc.2024.1390350 · Frontiers in Oncology · 2024-05-31

## TL;DR

A rare case of a mixed tumor in the ureter is reported, combining neuroendocrine and non-neuroendocrine features, diagnosed through surgery and chemotherapy.

## Contribution

First reported case of primary mixed neuroendocrine-non-neuroendocrine neoplasm in the ureter.

## Key findings

- The tumor had small cell neuroendocrine carcinoma and adenocarcinomatous components.
- Histopathological and immunohistochemical features confirmed the diagnosis of MiNEN.
- The patient remained disease-free after surgery and chemotherapy.

## Abstract

Cases of mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) of the urinary system are rare, and reports of primary MiNENs in the ureter are lacking. Herein, we present the case of a 71-year-old man who presented with painless gross hematuria and weight loss. Contrast-enhanced abdominal computed tomography (CT) revealed a tumor, comprising small cell neuroendocrine carcinoma (SCNEC) and adenocarcinomatous components, attached to the ureter. The SCNEC components were strongly positive for synaptophysin, CD56 and INSM1 and adenocarcinomatous components were strongly positive for CDX2 and cytokeratin 20, respectively. Four weeks post-surgery, the patient received four cycles of cisplatin-based chemotherapy; the 7-month follow-up CT confirmed that he was healthy without disease recurrence. The occurrence of MiNEN in the ureter with SCNEC and adenocarcinomatous components is extremely rare, wherein histopathological and immunohistochemical features aid in the diagnosis MiNEN. With its aggressive nature, MiNEN can only be effectively treated by early diagnosis and radical surgery.

## Linked entities

- **Proteins:** NCAM1 (neural cell adhesion molecule 1), INSM1 (INSM transcriptional repressor 1), CDX2 (caudal type homeobox 2)
- **Chemicals:** cisplatin (PubChem CID 5460033)
- **Diseases:** adenocarcinoma (MONDO:0004970), small cell neuroendocrine carcinoma (MONDO:0000402)

## Full-text entities

- **Genes:** INSM1 (INSM transcriptional repressor 1) [NCBI Gene 3642] {aka IA-1, IA1}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, CDX2 (caudal type homeobox 2) [NCBI Gene 1045] {aka CDX-3, CDX2/AS, CDX3}, SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}
- **Diseases:** SCNEC (MESH:D018288), weight loss (MESH:D015431), tumor (MESH:D009369), hematuria (MESH:D006417), disease (MESH:D004194), Ureter (MESH:D014516), MiNENs (MESH:D018358)
- **Chemicals:** cisplatin (MESH:D002945)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11176451/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11176451/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC11176451/full.md

---
Source: https://tomesphere.com/paper/PMC11176451